Tuesday, January 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Revises Price Target for Foot Locker Based on Market Conditions

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Morgan Stanley analyst Alex Straton reiterated an Equal-Weight rating for Foot Locker (NYSE:FL) but revised the price target down to $26 from $28. The adjustment was made based on the analyst’s evaluation of the company’s performance and prevailing market conditions.

FL Stock Analysis: Near Bottom of 52-Week Range, Investors Cautious About Future Prospects

On March 7, 2024, FL stock closed at $24.34, near the bottom of its 52-week range and below its 200-day simple moving average. The stock saw a modest increase of $0.10, or 0.41%, from the previous close, but dropped $0.04 in after-hours trading. FL’s weak price momentum and position near the bottom of its 52-week range suggest that investors may be cautious about its prospects in the near term. Investors should monitor FL’s performance closely for any potential breakout or further declines.

FL Stock Performance Analysis: Revenue, Net Income, and EPS Decline in 2024

On March 7, 2024, FL stock performance was under scrutiny as the company released its financial results for the past year and the fourth quarter. According to data from CNN Money, FL reported a total revenue of $8.17 billion for the past year, which was a decrease of 6.75% compared to the previous year. The total revenue for the fourth quarter was $2.38 billion, which remained flat compared to the previous quarter.

In terms of net income, FL reported a net loss of $330.00 million for the past year, which was a significant decrease of 196.49% compared to the previous year. However, the net loss for the fourth quarter was $389.00 million, which showed no change compared to the previous quarter.

Earnings per share (EPS) for FL were also on a downward trend, with a reported EPS of -$3.50 for the past year, a decrease of 197.82% compared to the previous year. The EPS for the fourth quarter was -$4.12, which showed no change compared to the previous quarter.

Overall, FL stock performance on March 7, 2024, was impacted by the decrease in total revenue, net income, and EPS compared to the previous year. Investors may be concerned about the company’s financial health and future prospects based on these results. It will be important for FL to address these challenges and implement strategies to improve its financial performance in the coming quarters.

Tags: FL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Stock Exchange

Analysts Bullish on BellRing Brands Strong Buy Recommendations and Positive Outlook

Unlocking Value: The Economic Potential of Iron-Titanium-Vanadium Projects

Westlake Corporation CFO Sells Shares Amid Financial Challenges

Analyst Ratings Show Bullish Sentiments for Boston Scientific

Recommended

Tesla Stock

Tesla’s Strategic Pivot: A Three-Pronged Transformation

2 months ago
Nio Stock

Nio’s Billion-Dollar Equity Raise Sends Shares Tumbling

4 months ago
Weyerhaeuser Stock

Weyerhaeuser Stock: A Study in Contradictory Market Signals

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Maintain Strong Upward Momentum

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Pfizer’s Strategic Shift Weighs on Investor Sentiment

Analyst Downgrade Overshadows PayPal’s Strategic Moves

Ethereum’s Quiet Consolidation Masks a Strengthening Foundation

Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle

Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

Trending

Novo Nordisk Stock
Earnings

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

by Dieter Jaworski
January 13, 2026
0

In a strategic pivot aimed at capturing a broader patient base, Novo Nordisk is aggressively promoting a...

CureVac Stock

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
MSCI World ETF Stock

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

January 13, 2026
Pfizer Stock

Pfizer’s Strategic Shift Weighs on Investor Sentiment

January 13, 2026
PayPal Stock

Analyst Downgrade Overshadows PayPal’s Strategic Moves

January 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach
  • CureVac’s Stock Journey Concludes Following BioNTech Acquisition
  • A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com